Application of a new preclinical drug screening system for cancer of the large bowel
- 1 February 1988
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 21 (1) , 31-34
- https://doi.org/10.1007/bf00262734
Abstract
We report a prospective evaluation of three human, continuous colorectal cancer cell lines and a new semiautomated radiometric technique (Bactec system) as a primary screening procedure for cytotoxic compounds with activity against cancer of the large bowel. COLO 320DM, Ht-29, and the metastatic OM-1 colon cancer cell line that have previously been shown to yield clinically relevant information in terms of drug sensitivity patterns in humans were all tested against 11 new compounds currently being investigated in phase I or early phase II clinical trials. Our results suggest that trimetrexate, DUP-785, didemnin B, and flavone-8-acetic acid may be clinically effective for the treatment of colorectal cancer.Keywords
This publication has 15 references indexed in Scilit:
- Interferon therapy in cancer: from imaginon to interferon.1986
- In Vitro activity of the novel antitumor antibiotic fostriecin (CI-920) in a human tumor cloning assayEuropean Journal of Cancer and Clinical Oncology, 1986
- Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning system.1985
- The use of human cancer cell lines as a primary screening system for antineoplastic compoundsEuropean Journal of Cancer and Clinical Oncology, 1984
- TRANSPORT OF THE ANTITUMOR ANTIBIOTIC CL-920 INTO L1210 LEUKEMIA-CELLS BY THE REDUCED FOLATE CARRIER SYSTEM1984
- CHARACTERIZATION OF 2 METASTATIC SUBPOPULATIONS ORIGINATING FROM A SINGLE HUMAN-COLON CARCINOMA1983
- A new method for in vitro chemosensitivity assay: inhibition of metabolic CO2 production.1983
- Human tumor xenografts in athymic nude mice as a preclinical screen for anticancer agents.1981
- Phase I Pharmacotoxicology Study of Human Fibroblast Interferon in Human Cancers23JNCI Journal of the National Cancer Institute, 1980
- CELL-LINES FROM HUMAN-COLON CARCINOMA WITH UNUSUAL CELL PRODUCTS, DOUBLE MINUTES, AND HOMOGENEOUSLY STAINING REGIONS1979